Mainstream

AstraZeneca beats Q4 top-line and bottom-line estimates; initiates FY25 outlook

AstraZeneca beats Q4 top-line and bottom-line estimates; initiates FY25 outlook

Post Contentazn, azncfRead More

You might also be interested in reading Titan Logix GAAP EPS of -$0.01, revenue of $1.49B.

February 6, 2025
In Mainstream